David J. Irwin

25.2k total citations · 3 hit papers
274 papers, 10.1k citations indexed

About

David J. Irwin is a scholar working on Physiology, Neurology and Psychiatry and Mental health. According to data from OpenAlex, David J. Irwin has authored 274 papers receiving a total of 10.1k indexed citations (citations by other indexed papers that have themselves been cited), including 122 papers in Physiology, 112 papers in Neurology and 91 papers in Psychiatry and Mental health. Recurrent topics in David J. Irwin's work include Alzheimer's disease research and treatments (114 papers), Parkinson's Disease Mechanisms and Treatments (85 papers) and Dementia and Cognitive Impairment Research (83 papers). David J. Irwin is often cited by papers focused on Alzheimer's disease research and treatments (114 papers), Parkinson's Disease Mechanisms and Treatments (85 papers) and Dementia and Cognitive Impairment Research (83 papers). David J. Irwin collaborates with scholars based in United States, Netherlands and United Kingdom. David J. Irwin's co-authors include John Q. Trojanowski, Virginia M.‐Y. Lee, Murray Grossman, Edward B. Lee, Vivianna M. Van Deerlin, Corey T. McMillan, Jon B. Toledo, Sharon X. Xie, John Robinson and Howard I. Hurtig and has published in prestigious journals such as Cell, The Lancet and Journal of Biological Chemistry.

In The Last Decade

David J. Irwin

259 papers receiving 9.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Stages of pTDP‐43 pathology in amyotrophic lateral sclerosis

2013 750 citations John Robinson, David J. Irwin et al. profile →
Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies

2013 685 citations David J. Irwin, Virginia M.‐Y. Lee et al. profile →
SpaGCN: Integrating gene expression, spatial location and histology to identify spatial domains and spatially variable genes by graph convolutional network

2021 450 citations David J. Irwin, Edward B. Lee et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David J. Irwin United States	50	4.9k	4.1k	2.7k	2.1k	1.6k	274	10.1k
Vivianna M. Van Deerlin United States	53	6.0k 1.2×	4.1k 1.0×	2.4k 0.9×	1.5k 0.7×	2.1k 1.3×	148	9.6k
Patrick Vermersch France	54	4.6k 0.9×	2.6k 0.6×	1.9k 0.7×	2.1k 1.0×	1.5k 0.9×	391	13.7k
Adam L. Boxer United States	56	4.3k 0.9×	4.6k 1.1×	2.9k 1.1×	3.1k 1.5×	2.2k 1.3×	213	11.4k
Jillian J. Kril Australia	59	4.7k 1.0×	3.6k 0.9×	2.2k 0.8×	2.2k 1.1×	2.3k 1.4×	195	11.9k
Marcel M. Verbeek Netherlands	65	4.4k 0.9×	5.1k 1.2×	4.1k 1.5×	2.2k 1.1×	2.2k 1.3×	294	12.9k
Mark S. Forman United States	47	4.7k 1.0×	4.0k 1.0×	2.9k 1.1×	1.3k 0.6×	1.7k 1.0×	82	9.1k
Edward B. Lee United States	53	4.9k 1.0×	4.2k 1.0×	3.7k 1.4×	1.4k 0.7×	1.9k 1.2×	208	10.6k
Thomas Arzberger Germany	46	4.3k 0.9×	3.3k 0.8×	3.6k 1.3×	1.0k 0.5×	1.7k 1.0×	116	9.7k
Simon Mead United Kingdom	51	3.2k 0.7×	2.9k 0.7×	4.9k 1.8×	1.3k 0.6×	2.9k 1.8×	195	9.1k
Barbara Borroni Italy	60	4.8k 1.0×	5.0k 1.2×	2.2k 0.8×	3.4k 1.6×	3.3k 2.0×	361	13.1k

Countries citing papers authored by David J. Irwin

Since Specialization

Citations

This map shows the geographic impact of David J. Irwin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David J. Irwin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David J. Irwin more than expected).

Fields of papers citing papers by David J. Irwin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David J. Irwin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David J. Irwin. The network helps show where David J. Irwin may publish in the future.

Co-authorship network of co-authors of David J. Irwin

This figure shows the co-authorship network connecting the top 25 collaborators of David J. Irwin. A scholar is included among the top collaborators of David J. Irwin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David J. Irwin. David J. Irwin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Irwin, David J.. (2025). The potential of TDP-43 PET ligands for a biological diagnosis of TDP-43 proteinopathies. Nature Communications. 16(1). 9357–9357.

Cho, Sunghye, Sharon Ash, Katheryn A Q Cousins, et al.. (2025). Automatic quantification of syntactic complexity in natural spontaneous speech of people with primary progressive aphasia. Aphasiology. 40(3). 561–582.

Vermunt, Lisa, Carel F.W. Peeters, Emma L. van der Ende, et al.. (2025). Large-scale CSF proteome profiling identifies biomarkers for accurate diagnosis of frontotemporal dementia. Molecular Neurodegeneration. 20(1). 93–93. 1 indexed citations

Cousins, Katheryn A Q, Jeffrey S. Phillips, Sandhitsu R. Das, et al.. (2024). Pathologic and cognitive correlates of plasma biomarkers in neurodegenerative disease. Alzheimer s & Dementia. 20(6). 3889–3905. 16 indexed citations

Das, Sandhitsu R., Christopher A. Olm, Katheryn A Q Cousins, et al.. (2024). Posterior hippocampal sparing in Lewy body disorders with Alzheimer’s copathology: An in vivo MRI study. NeuroImage Clinical. 45. 103714–103714. 1 indexed citations

McMillan, Corey T., et al.. (2023). Racial Differences in Clinical Presentation in Individuals Diagnosed With Frontotemporal Dementia. JAMA Neurology. 80(11). 1191–1191. 3 indexed citations

Ende, Emma L. van der, Sjors G. J. G. In ‘t Veld, Sven J. van der Lee, et al.. (2023). CSF proteomics in autosomal dominant Alzheimer’s disease highlights parallels with sporadic disease. Brain. 146(11). 4495–4507. 27 indexed citations

Shellikeri, Sanjana, Sunghye Cho, Sharon Ash, et al.. (2023). Digital markers of motor speech impairments in spontaneous speech of patients with ALS-FTD spectrum disorders. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 25(3-4). 317–325. 1 indexed citations

Campo, Marta del, Lisa Vermunt, Carel F.W. Peeters, et al.. (2023). CSF proteome profiling reveals biomarkers to discriminate dementia with Lewy bodies from Alzheimer´s disease. Nature Communications. 14(1). 5635–5635. 31 indexed citations

10.

Uemura, Maiko, Eun Ran Suh, John Robinson, et al.. (2022). Abundant copathologies of polyglucosan bodies, frontotemporal lobar degeneration with TDP‐43 inclusions and ageing‐related tau astrogliopathy in a family with a GBE1 mutation. Neuropathology and Applied Neurobiology. 49(1). e12865–e12865. 4 indexed citations

11.

Cousins, Katheryn A Q, Sanjana Shellikeri, Daniel T. Ohm, et al.. (2022). CSF Biomarkers of Alzheimer Disease in Patients With Concomitant α-Synuclein Pathology. Neurology. 99(20). e2303–e2312. 13 indexed citations

12.

Shellikeri, Sanjana, Sunghye Cho, Katheryn A Q Cousins, et al.. (2022). Natural speech markers of Alzheimer's disease co-pathology in Lewy body dementias. Parkinsonism & Related Disorders. 102. 94–100. 7 indexed citations

13.

Coughlin, David G., Annie Hiniker, Claire Peterson, et al.. (2022). Digital Histological Study of Neocortical Grey and White Matter Tau Burden Across Tauopathies. Journal of Neuropathology & Experimental Neurology. 81(12). 953–964. 7 indexed citations

14.

Burke, Sarah, Jeffrey S. Phillips, Christopher A. Olm, et al.. (2022). Phases of volume loss in patients with known frontotemporal lobar degeneration spectrum pathology. Neurobiology of Aging. 113. 95–107. 6 indexed citations

15.

Cho, Sunghye, Katheryn A Q Cousins, Sanjana Shellikeri, et al.. (2022). Lexical and Acoustic Speech Features Relating to Alzheimer Disease Pathology. Neurology. 99(4). e313–e322. 27 indexed citations

16.

Cousins, Katheryn A Q, David J. Irwin, David A. Wolk, et al.. (2020). ATN status in amnestic and non-amnestic Alzheimer’s disease and frontotemporal lobar degeneration. Brain. 143(7). 2295–2311. 28 indexed citations

17.

Phillips, Jeffrey S., Fulvio Da Re, Sharon X. Xie, et al.. (2017). Neocortical origin and progression of gray matter atrophy in nonamnestic Alzheimer's disease. Neurobiology of Aging. 63. 75–87. 52 indexed citations

18.

Phillips, Jeffrey S., Sandhitsu R. Das, Corey T. McMillan, et al.. (2017). Tau PET imaging predicts cognition in atypical variants of Alzheimer's disease. Human Brain Mapping. 39(2). 691–708. 49 indexed citations

19.

Irwin, David J., et al.. (2002). Disposal of syringes, needles, and lancets used by diabetic patients in North East Essex.. PubMed. 5(2). 134–7. 8 indexed citations

20.

Irwin, David J.. (1972). Neo-Classical Design: Industry Plunders Antiquity. Apollo: The international magazine of arts. 288–297.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact